These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12169712)

  • 41. Market medicine.
    Woolhandler S; Himmelstein DU
    Epidemiol Prev; 1997; 21(2):89-90. PubMed ID: 9286140
    [No Abstract]   [Full Text] [Related]  

  • 42. A poke in the pocketbook.
    Kiser K
    Minn Med; 2012 Aug; 95(8):14-7. PubMed ID: 22953468
    [No Abstract]   [Full Text] [Related]  

  • 43. Vaccine development and deployment: opportunities and challenges in India.
    Gupta SS; Nair GB; Arora NK; Ganguly NK
    Vaccine; 2013 Apr; 31 Suppl 2():B43-53. PubMed ID: 23598492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term solutions for the problem of vaccine shortages.
    Lattanzi M; Rappuoli R
    Expert Opin Biol Ther; 2004 Jun; 4(6):989-92. PubMed ID: 15174980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Financing immunization of adults in the United States.
    Orenstein WA; Mootrey GT; Pazol K; Hinman AR
    Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The economics of vaccination in low- and middle-income countries.
    Fox-Rushby JA; Kaddar M; Levine R; Brenzel L
    Bull World Health Organ; 2004 Sep; 82(9):640. PubMed ID: 15628198
    [No Abstract]   [Full Text] [Related]  

  • 49. Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs.
    Rybak MJ; Allen R; Craven PC; Freeman R; Nightingale CH; Normand C; Rubinstein E; Schaison GS; Whitelaw G
    Hosp Formul; 1993 Jan; 28 Suppl 1():33-6. PubMed ID: 10123836
    [No Abstract]   [Full Text] [Related]  

  • 50. Developing drugs for developing countries.
    Ridley DB; Grabowski HG; Moe JL
    Health Aff (Millwood); 2006; 25(2):313-24. PubMed ID: 16522573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm.
    Jacobson SH; Karnani T; Sewell EC
    Vaccine; 2004 Jun; 22(17-18):2307-15. PubMed ID: 15149790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 53. American pharmaceutical prices.
    Alagona P
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
    [No Abstract]   [Full Text] [Related]  

  • 54. [The National Board of Health and Welfare has the last word].
    Lindberg A; Möllergren M; Tegnell A
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1685-7. PubMed ID: 18590012
    [No Abstract]   [Full Text] [Related]  

  • 55. Global vaccine project gets a shot in the arm.
    Check E
    Nature; 2005 Jan; 433(7024):345. PubMed ID: 15674258
    [No Abstract]   [Full Text] [Related]  

  • 56. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indian-born weapons for infectious diseases.
    Padmanaban G
    Nat Med; 2003 Jul; 9(7):813. PubMed ID: 12835687
    [No Abstract]   [Full Text] [Related]  

  • 58. The U.S. vaccine supply.
    Hinman AR
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15758020
    [No Abstract]   [Full Text] [Related]  

  • 59. Reforming Canada's Access to Medicines Regime.
    Elliott R
    CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
    [No Abstract]   [Full Text] [Related]  

  • 60. The economics of vaccination from a global perspective: present and future. 2-3 December, 2004, Vaccines: all things considered, San Francisco, CA, USA.
    Ehreth J
    Expert Rev Vaccines; 2005 Feb; 4(1):19-21. PubMed ID: 15757469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.